• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.

作者信息

Kwon O W, Kang S J, Lee J B, Lee S C, Yoon Y D, Oh J H

机构信息

Department of Opthalmology, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Ophthalmologica. 1998;212(2):120-5. doi: 10.1159/000027295.

DOI:10.1159/000027295
PMID:9486552
Abstract

We evaluated the efficacy of tissue plasminogen activator in treating experimental suprachoroidal hemorrhage. Suprachoroidal hemorrhage was created in 30 white rabbit eyes by implanting four pieces of small, exogenously formed blood coagula into the suprachoroidal space. Animals were randomized for treatment with a surgical sponge soaked in 25, 50, or 75 microg of tissue plasminogen activator (tPA) or balanced salt solution (BSS) as a control. The time when initiation and completion of clot dissolution occurred was established, and histological examination was performed to assess damage. Clot dissolution started within 30 min in the 50- and 75-microg tPA group, whereas it took 2.75 days in the control group; complete dissolution of blood clots took 4.5 h in the 75-microg tPA group and 14 days in the control group. Histological examination revealed a minimal change in photoreceptors within 6 h after treatment with 75 microg tPA. Treatment of suprachoroidal hemorrhage with tPA seems to be effective, but further investigations for determining the effective and nontoxic dose are required.

摘要

相似文献

1
Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
Ophthalmologica. 1998;212(2):120-5. doi: 10.1159/000027295.
2
Treatment of experimental suprachoroidal hemorrhage with subconjunctival injection of tissue plasminogen activator: a negative report.结膜下注射组织型纤溶酶原激活剂治疗实验性脉络膜上腔出血:一份阴性报告。
Ophthalmic Surg. 1990 Sep;21(9):641-3.
3
Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.
Int Ophthalmol. 1990 Jul;14(4):267-70. doi: 10.1007/BF00159862.
4
The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model.玻璃体腔内注射组织型纤溶酶原激活剂在猪模型实验性视网膜下出血治疗中的应用。
Retina. 1996;16(6):518-24. doi: 10.1097/00006982-199616060-00009.
5
Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.玻璃体内注射组织型纤溶酶原激活剂对实验性视网膜下出血的影响。
Retina. 1995;15(4):319-26. doi: 10.1097/00006982-199515040-00009.
6
The effect of tissue plasminogen activator on premacular hemorrhage.组织型纤溶酶原激活剂对黄斑前出血的影响。
Ophthalmic Surg Lasers. 2001 Jan-Feb;32(1):7-12.
7
Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage.
Ophthalmology. 1992 Apr;99(4):515-21. doi: 10.1016/s0161-6420(92)31939-6.
8
Tissue plasminogen activator in the treatment of vitreoretinal diseases.
Semin Ophthalmol. 2000 Mar;15(1):44-50. doi: 10.3109/08820530009037850.
9
Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots.红细胞启发的盘状聚合物纳米构建体携带组织型纤溶酶原激活剂,用于增强血栓的溶解。
ACS Nano. 2018 Dec 26;12(12):12224-12237. doi: 10.1021/acsnano.8b06021. Epub 2018 Nov 16.
10
Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.与全身性溶栓药物使用相关的出血性眼部并发症。
Ophthalmology. 1998 Mar;105(3):428-31. doi: 10.1016/S0161-6420(98)93023-8.

引用本文的文献

1
Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis.重组组织型纤溶酶原激活剂辅助下早期引流累及黄斑的大量脉络膜上腔出血可能导致更好的视觉预后。
Case Rep Ophthalmol. 2025 May 2;16(1):385-394. doi: 10.1159/000545290. eCollection 2025 Jan-Dec.
2
A Stepwise Approach to the Surgical Management of Hemorrhagic Choroidal Detachments.出血性脉络膜脱离手术治疗的逐步方法
J Vitreoretin Dis. 2021 Mar 2;6(2):111-115. doi: 10.1177/2474126421992024. eCollection 2022 Mar-Apr.
3
Modified posterior drainage of post-operative suprachoroidal hemorrhage.
改良式术后脉络膜上腔出血引流术。
Indian J Ophthalmol. 2021 Dec;69(12):3584-3590. doi: 10.4103/ijo.IJO_3533_20.
4
Suprachoroidal hemorrhage associated with pars plana vitrectomy.与扁平部玻璃体切割术相关的脉络膜上腔出血。
BMC Ophthalmol. 2021 Aug 11;21(1):295. doi: 10.1186/s12886-021-02062-7.
5
Suprachoroidal haemorrhage (SCH) drainage using suprachoroidal tissue plasminogen activator (t-PA) after complicated cataract extraction (two-staged procedure): early intervention could mean better vision.复杂白内障摘除术后(两阶段手术)使用脉络膜上腔组织纤溶酶原激活剂(t-PA)引流脉络膜上腔出血(SCH):早期干预可能意味着更好的视力。
BMJ Case Rep. 2021 May 6;14(5):e241705. doi: 10.1136/bcr-2021-241705.
6
Tissue plasminogen activator-assisted vitrectomy in the early treatment of acute massive suprachoroidal hemorrhage complicating cataract surgery.组织型纤溶酶原激活剂辅助玻璃体切除术治疗白内障手术并发急性大量脉络膜上腔出血的早期治疗
Int J Ophthalmol. 2018 Jan 18;11(1):170-171. doi: 10.18240/ijo.2018.01.27. eCollection 2018.
7
Tissue plasminogen activator-assisted vitrectomy for ruptured eye with suprachoroidal hemorrhage.组织型纤溶酶原激活剂辅助玻璃体切除术治疗伴有脉络膜上腔出血的眼球破裂伤。
Case Rep Ophthalmol. 2012 May;3(2):258-61. doi: 10.1159/000342136. Epub 2012 Aug 16.
8
Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage.重组组织型纤溶酶原激活剂治疗脉络膜上腔出血
Clin Ophthalmol. 2011;5:155-7. doi: 10.2147/OPTH.S16134. Epub 2011 Feb 4.